Indication

Bartonellosis

Bartonellosis refers to a group of zoonotic and vector-borne infectious diseases caused by facultative intracellular, gram-negative bacteria of the genus *Bartonella*, primarily *B. Read more about Bartonellosis

194 drugs 105 manufacturers

Advertisement

Drugs that treat it

Common Bartonellosis therapies.

Showing 190–194 of 194 drugs

Filter & compare in the drug finder →Opens the drug finder with Bartonellosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bartonellosis.

Bartonellosis refers to a group of zoonotic and vector-borne infectious diseases caused by facultative intracellular, gram-negative bacteria of the genus *Bartonella*, primarily *B.

henselae*, *B.

quintana*, and *B.

bacilliformis*.

The infection primarily targets the reticuloendothelial, vascular endothelial, and hematologic systems, manifesting across diverse patient populations ranging from healthy hosts to severely immunocompromised individuals.

Pathophysiologically, the bacteria parasitize erythrocytes and induce endothelial cell proliferation and angiogenesis.

Clinical presentations vary by species and immune status, encompassing self-limiting regional lymphadenopathy and fever (cat-scratch disease), relapsing febrile bacteremia (trench fever), hemolytic anemia and eruptive angiomatous skin lesions (Carrión disease), as well as invasive complications such as culture-negative endocarditis, bacillary angiomatosis, and peliosis hepatis.

Personalize your experience

Follow Bartonellosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it